# Hydroxychloroquine Administration for Reduction of Pexophagy

> **NCT03856866** · PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 3 (actual)

## Conditions studied

- Zellweger Syndrome
- Peroxisome Biogenesis Disorders

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03856866
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-11
- **Primary completion:** 2020-05-05
- **Final completion:** 2020-05-05
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03856866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03856866, "Hydroxychloroquine Administration for Reduction of Pexophagy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03856866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*